List of works - Marcio Lasaro

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

scientific article published on 16 January 2007

A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge

scientific article

Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice

scientific article published on 17 May 2011

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

scientific article published on May 2009

Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.

scientific article

Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine.

scientific article published on January 2003

Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway.

scientific article published on 21 April 2010

Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates

scientific article published on 17 May 2011

Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived en

scientific article

Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques

scientific article published on 27 December 2012

Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles

scientific article published on 04 June 2019

Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

scientific article published on 11 March 2009

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

scientific article published on 11 April 2007

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.

scientific article published on 10 June 2016

Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein D ⬇️

scientific article published on August 25, 2010

Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents

scientific article published on 09 December 2013

Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn.

scientific article published on 8 August 2017

New insights on adenovirus as vaccine vectors

scientific article published on 09 June 2009

Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system

scientific article published on 08 January 2009

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes

scientific article published on 23 January 2007

Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

scientific article

Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice

scientific article

Targeting inhibitory pathways in cancer immunotherapy

scientific article

Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

scientific article published on 13 January 2008

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

scientific article published in February 2007

Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality

scientific article (publication date: 22 December 2010)

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques

scientific article

List of works by Marcio Lasaro

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge

Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.

Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine.

Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway.

Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates

Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived en

Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques

Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles

Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.

Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein D ⬇️

Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents

Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn.

New insights on adenovirus as vaccine vectors

Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes

Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice

Targeting inhibitory pathways in cancer immunotherapy

Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques